Physician profile
Deepankar Sharma
NPI 1285947226
$13,435.10
in general payments reported to CMS, 2019-2025
6 companies · $732 in 2025
The $732 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2021: $3,524 · 2022: $850 · 2023: $6,323 · 2024: $475 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,025 · Travel and Lodging: $287 · Gift: $180 · Food and Beverage: $19.03 · Education: $18.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,025.00 |
| Travel and Lodging | $287.00 |
| Gift | $180.00 |
| Food and Beverage | $19.03 |
| Education | $18.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $11,012.00 | 2021-2025 | Aero Stent and Delivery System, Elation Balloon Dilator, Aeromini Stent and Delivery System |
| Pulmonx Corporation | $1,505.83 | 2019 | |
| Intuitive Surgical, INC. | $854.00 | 2021-2023 | Da Vinci Surgical System |
| Olympus Corporation of The Americas | $25.76 | 2019 | |
| Insmed, INC. | $19.03 | 2025 | Arikayce |
| Amgen INC. | $18.48 | 2023 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepankar Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.